NCT06393062

Brief Summary

In this study, investigators compared the systemic inflammatory responses after percutaneous nephrolithotomy (PCNL) patients who were given an expanded empirical antibiotic regimen based on the prediction of the possibility of bacteria identified by Gram staining the first urine after renal puncture and patients whose antibiotic regimen was not performed and whose antibiotic regimen was adjusted according to patient symptoms and culture results. Investigators aimed to test its diagnostic value in predicting and preventing complications.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
245

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2022

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

April 24, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

May 1, 2024

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2025

Completed
Last Updated

January 22, 2025

Status Verified

January 1, 2025

Enrollment Period

2.8 years

First QC Date

April 24, 2024

Last Update Submit

January 20, 2025

Conditions

Keywords

fevergram stainpercutaneous nephrolithotomySystemic inflammatory response syndrome (SIRS)

Outcome Measures

Primary Outcomes (1)

  • Efficacy of Gram stain in predicting systemic inflammatory response after percutaneous nephrolithotomy.

    Gram staining of urine after puncture to detect the presence of bacteria that are a possible source of infection according to the rate of gram-stained and non-gram-stained patients by microscopic examination.

    immediately after the surgery

Secondary Outcomes (1)

  • Change of antibiotic regimen after bacterial estimation of Gram stain

    immediately after the surgery

Study Arms (2)

Gram staining

EXPERIMENTAL

Gram staining of post-puncture urine in percutaneous nephrolithotomy

Diagnostic Test: Gram staining of the first urine after intraoperative renal puncture to predict the systemic inflammatory response after percutaneous nephrolithotomy.

control

NO INTERVENTION

non-intervention percutaneous nephrolithotomy

Interventions

Gram staining of the first urine after intraoperative renal puncture to predict the systemic inflammatory response after percutaneous nephrolithotomy.

Gram staining

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients with an indication for percutaneous nephrolithotomy due to kidney stone disease.

You may not qualify if:

  • under 18 years old,
  • having an active urinary tract infection before surgery and positive urine cultures,
  • Patients with bilateral kidney stones,
  • DJ stent or nephrostomy placement,
  • Solitary kidney stones,
  • Bleeding disorders,
  • impaired kidney function,
  • a history of antibiotic use for any reason within 2 weeks before randomization were excluded from the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Adıyaman University, Medicine of Faculty

Adıyaman, 02400, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

FeverSystemic Inflammatory Response Syndrome

Condition Hierarchy (Ancestors)

Body Temperature ChangesSigns and SymptomsPathological Conditions, Signs and SymptomsInflammationPathologic ProcessesShock

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: The patients included in the study were randomized by a block randomization method by an independent researcher, hidden from the patients and the responsible clinicians, using a computerized number tool.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant professor doctor

Study Record Dates

First Submitted

April 24, 2024

First Posted

May 1, 2024

Study Start

December 1, 2022

Primary Completion

August 31, 2025

Study Completion

September 30, 2025

Last Updated

January 22, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will share

Patient clinical data before and after surgery

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
starting 6 months after publication
Access Criteria
Data will be shared with all researchers conducting research on the prevention and detection of infectious consequences after percutaneous nephrolithotomy.

Locations